Global X S&P Biotech ETF CURE.AX · ETF Open Global X S&P Biotech ETF in new tab
Weights
Sector Weights
Country Weights
United States
Ireland
United Kingdom
Switzerland
Netherlands
Canada
Global X S&P Biotech ETF Analysis (CURE.AX)
Investment Objective: Global X S&P Biotech ETF is an investment vehicle . It is currently trading at 73.91 AUD.
Portfolio Composition:
The fund is heavily weighted towards
the Healthcare sector (100%),
the Financial Services sector (0%)
and markets in
United States (95%),
Ireland (1%),
United Kingdom (1%)
.
For a full breakdown of all holdings, see the "Weights" card above.
Income: This appears to be an accumulating fund (dividends are reinvested) or focuses purely on capital growth.
Investor FAQ
Does Global X S&P Biotech ETF pay a dividend?
No, it does not currently pay a dividend.
What asset class is Global X S&P Biotech ETF?
Global X S&P Biotech ETF is classified as a ETF. You can compare it against its peer in the "Related Symbols" list.
Fund Strategy
No detailed summary available for Global X S&P Biotech ETF.
| Year | Total Dividends |
|---|---|
| ▸2022 |
0.02 AUD
|
| July 15, 2022 | 0.0240 |
| ▸2021 |
6.26 AUD
|
| July 15, 2021 | 6.2602 |
| ▸2020 |
6.76 AUD
|
| July 15, 2020 | 6.7562 |
| ▸2019 |
1.17 AUD
|
| July 15, 2019 | 1.1739 |
Community Discussion